Every little step in fields like this is so encouraging. We keep getting better, but the cancers don't.
Ever more effective cocktails of drugs that target the cancers while minimising harm to everywhere else, the closer we get to attacking cancer cells from so many different directions they simply can't adapt in time and we wipe it out immediately (a cure). One can only hope.
I whether we might see even more investment into research like this as it gets closer to deliver curative, rather than just suppressive outcomes, as well
Pfizer acquired Seagen for $43 billion. Seagen has some very promising ADC’s in the queue.
https://www.pfizer.com/news/press-release/press-release-deta...
Every little step in fields like this is so encouraging. We keep getting better, but the cancers don't.
Ever more effective cocktails of drugs that target the cancers while minimising harm to everywhere else, the closer we get to attacking cancer cells from so many different directions they simply can't adapt in time and we wipe it out immediately (a cure). One can only hope.
I whether we might see even more investment into research like this as it gets closer to deliver curative, rather than just suppressive outcomes, as well
CAR-T may have a ~50% cure rate for blood cancers: https://ashpublications.org/blood/article/141/19/2307/494672...
> whether we might see even more investment into research
The field would benefit greatly from even a fraction of the investment in the AI and crypto bubbles